인쇄하기
취소
|
The government is planning to enlarge support for new drug development in the initial phase, reduce the support in the commercialization phase, like Phase 3 clinical trials, and promote investments into private companies.
The Ministry of Science, ICT and Future Planning(MSIP) announced the plan for R&D investment into the life and medical field, such as new drug and stem cell, at the ‘2018 Gov...